Prescribing information: difference between revisions
Diff·revision 9 → 10·01:03, 28 Jan 2025
Difference between revision 9 and revision 10 of Prescribing information. 6 lines changed; the page grew by 135 bytes.
| Revision 9 — 03:46, 2 Jan 2025 IpamorelinIsold (talk) add category for pricing 3,323 bytes +850 | Revision 10 — 01:03, 28 Jan 2025 CostPerMgCory (talk) add the manufacturer assistance programme with its eligibility criterion 3,458 bytes +135 | ||
|---|---|---|---|
| 38 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 38 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 39 | 39 | ||
| + | 40 | == See also == | |
| + | 41 | * [[Contraindications of incretin therapy]] | |
| + | 42 | * [[Telehealth prescribing]] | |
| + | 43 | * [[Prior authorisation]] | |
| + | 44 | * [[Off-label use]] | |
| + | 45 | ||
| 40 | {{DEFAULTSORT:Prescribing information}} | 46 | {{DEFAULTSORT:Prescribing information}} |
| 41 | [[Category:Prescribing and telehealth]] | 47 | [[Category:Prescribing and telehealth]] |